Medical inquiries

Connect with my medical science liaison

Chat live

Available Monday - Friday 9AM - 4:30PM ET

Call me now

Available Monday - Friday 9AM - 7:30PM ET

Email your inquiry

Call 1-800-526-7736

Available Monday - Friday 9AM - 8PM ET

Live video

Available Monday - Friday 9AM - 4:30PM ET

This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

DARZALEX® (daratumumab)

Medical Information

+ Save link

DARZALEX - Latex Content

Last Updated: 10/22/2024

SUMMARY

DARZALEX is supplied as a colorless to yellow preservative-free liquid concentrate for intravenous infusion after dilution and is supplied in single-dose vials.¹
The excipients and immediate container do not contain latex/natural rubber. However, it cannot be guaranteed that the materials do not come in contact with latex during the manufacturing or packaging process (e.g., latex gloves).²

Literature Search

A literature search of MEDLINE^®, Embase^®, BIOSIS Previews^®, and Derwent Drug File databases (and/or other resources, including internal/external databases) was conducted on 21 October 2024.

References

Show

1	Data on File. Daratumumab IV Company Core Data Sheet (CCDS). Janssen Research & Development, LLC. EDMS-ERI-78724630; 2024.
2	Data on File. Technical Document Patient Safety and Compliance Information for Darzalex. Janssen Research & Development, LLC. TV-TEC-161006; 2024.